Efficacy and Safety of Latanoprost for Glaucoma Treatment: A Three-Month Multicentric Study in India

Efficacy and Safety of Latanoprost for Glaucoma Treatment: A Three-Month Multicentric Study in India

PURPOSE: To evaluate the short-term efficacy and safety of 0.005% topical latanoprost in Indian eyes. DESIGN: Prospective non-randomised open-label multicentric trial. METHODS: One hundred and fifty patients with ocular hypertension (OHT), primary open-angle, pseudoexfoliation or pigment...

Full description

Bibliographic Details
Main Authors:	Thomas Ravi, Parikh Rajul, Sood Devendra, Vijaya L, Chandra Sekhar G, Sood Narendra, Baskaran M, Kalyani Prasad K
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2005-03-01
Series:	Indian Journal of Ophthalmology
Subjects:	Latanoprost safety efficacy glaucoma Indian eyes
Online Access:	http://www.ijo.in/article.asp?issn=0301-4738;year=2005;volume=53;issue=1;spage=23;epage=30;aulast=

Similar Items

Effect of latanoprost on open angle glaucoma
by: Min Zhang, et al.
Published: (2018-06-01)

Efficacy and safety of Latanoprost/Timolol fixed combinations in treatment of refractory glaucoma following vitrectomy in short period
by: Ting Wang, et al.
Published: (2013-09-01)

Comparison between latanoprost and brimonidine efficacy and safety in Indian eyes
by: Thomas Ravi, et al.
Published: (2003-01-01)

Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction
by: Beck DER, et al.
Published: (2017-08-01)

Comparing the efficacy of Xalatan and a similar latanoprost(Drenatan)in open angle glaucoma patients
by: Bernardo de Pádua Soares Bezerra, et al.
Published: (2017-10-01)

Comparison study of intraocular pressure reduction efficacy and safety between latanoprost and tafluprost in Japanese with normal-tension glaucoma
by: Ikeda Y, et al.
Published: (2016-08-01)

Latanoprost PF vs. Bimatoprost PF: Which Treats the Ocular Surface Better?
by: Georgios S. Dimtsas, et al.
Published: (2023-10-01)

Long-Term Effectiveness and Safety of Tafluprost, Travoprost, and Latanoprost in Korean Patients with Primary Open-Angle Glaucoma or Normal-Tension Glaucoma: A Multicenter Retrospective Cohort Study (LOTUS Study)
by: Joon-Mo Kim, et al.
Published: (2021-06-01)

Comparison of clinical effects of two latanoprost 0.005% solutions (Xalatan® and Arulatan®) in primary open-angle glaucoma or ocular hypertensive patients: a randomized clinical trial
by: Brant Fernandes RA, et al.
Published: (2019-04-01)

Effect of latanoprost combined with timolol treatment on visual function, intraocular pressure and ocular blood flow of open angle glaucoma
by: Yan-Xia Zhao
Published: (2015-01-01)

Comparison of the Safety and Efficacy between Preserved and Preservative-Free Latanoprost and Preservative-Free Tafluprost
by: Joon Mo Kim, et al.
Published: (2021-05-01)

Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study
by: Economou MA, et al.
Published: (2018-11-01)

Síncope e hipotensión arterial como efecto adverso de latanoprost
by: Gabriel E. Ortiz Arismendi, et al.
Published: (2022-10-01)

Intraocular pressure and visual field changes in normal-tension glaucoma patients treated using either unoprostone or latanoprost: a prospective comparative study
by: Takemoto D, et al.
Published: (2017-09-01)

Peripheral Latanoprost Administration Lowers Intraocular Pressure in the Wistar Rat
by: Maciej Świątkiewicz, et al.
Published: (2020-08-01)

Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma
by: Yulong Wang, et al.
Published: (2020-11-01)

Comparison of the Effect on Vessel Density and RNFL between Carteolol and Latanoprost
by: Elena Nutterova, et al.
Published: (2022-07-01)

Efficacy and Tolerability of a New Latanoprost 0.005% BAK-Free Nanoemulsion: A Nonrandomized Open-Label Trial
by: Javier F. Casiraghi, et al.
Published: (2021-01-01)

Efficacy and safety of latanoprost/timolol fixed combination dosed twice daily compared to once daily in patients with primary open angle glaucoma
by: Anis Baidura Azal, et al.
Published: (2023-08-01)

Physiochemical Properties and Cytotoxicity of a Benzalkonium Chloride-Free, Micellar Emulsion Ophthalmic Formulation of Latanoprost
by: Halder A, et al.
Published: (2020-10-01)

Efficacy of Nimodipine Combined with Latanoprost in Treating Open-Angle Glaucoma and Its Influence on Ocular Hemodynamics and Visual Field Defects
by: Duan HP, et al.
Published: (2022-03-01)

Comparación de Latanoprostene bunod 0,024 % y Latanoprost 0,005 % en glaucoma de ángulo abierto e hipertensión ocular
by: David Mateo Careaga Cacace, et al.
Published: (2023-02-01)

Improved Efficacy of Topical Latanoprost 0.005% Demonstrated by Corneal Biomechanical Correcting Modified Goldmann Prism
by: Radcliffe N, et al.
Published: (2020-08-01)

Preservative-Free versus Benzalkonium Chloride–Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial
by: Bacharach J, et al.
Published: (2023-09-01)

Short-term efficacy analysis of domestic and imported prostaglandins on treating open angle glaucoma
by: Zhen-Chao Chen, et al.
Published: (2016-02-01)

Preservative-Free versus Benzalkonium Chloride–Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial [Corrigendum]
by: Bacharach J, et al.
Published: (2023-09-01)

Short term effects of latanoprost on intraocular pressure, central corneal thickness and anterior chamber depth in open angle glaucoma
by: Cemal Cavdarli, et al.
Published: (2015-12-01)

Cost–Utility Analysis of a Latanoprost Cationic Emulsion (STN1013001) versus Other Latanoprost in the Treatment of Open-Angle Glaucoma or Ocular Hypertension and Concomitant Ocular Surface Disease in Germany
by: Lazzaro C, et al.
Published: (2022-02-01)

Efficacy and safety of netarsudil/latanoprost fixed-dose combination vs. monotherapy in open-angle glaucoma or ocular hypertension: A systematic review and meta-analysis of randomized controlled trials
by: Nachuan Luo, et al.
Published: (2022-08-01)

Efficacy and safety of bimatoprost in glaucoma and ocular hypertension in non-responder patients
by: Nicholas Brennan, et al.
Published: (2017-08-01)

Comparison of the Efficacy of Latanoprost, Bimatoprost, and Travoprost in Patients with Primary Open-Angle Glaucoma and Ocular Hypertension
by: Nur Çolak, et al.
Published: (2014-05-01)

The Efficacy of Latanoprost in the Treatment of Alopecia Areata of Eyelashes and Eyebrows
by: Gita Faghihi, et al.
Published: (2012-03-01)

Crossover randomized study comparing the efficacy and tolerability of preservative-free Tafluprost 0.0015% to Latanoprost 0.005% in patients with primary open-angle glaucoma
by: Sherein M Hagras, et al.
Published: (2021-01-01)

The effect on intraocular pressure of Latanoprost with once every other day dosing in glaucoma patients
by: Rana Sorkhabi, et al.
Published: (2013-04-01)

Comparison of adherence between fixed and unfixed topical combination glaucoma therapies using Japanese healthcare/pharmacy claims database: a retrospective non-interventional cohort study
by: Chikako Shirai, et al.
Published: (2021-01-01)

Impact of Latanoprost Antiglaucoma Eyedrops and Their Excipients on Toxicity and Healing Characteristics in the Ex Vivo Eye Irritation Test System
by: Claudia Panfil, et al.
Published: (2023-07-01)

Topical latanoprost solution in combination with microneedling in treatment of segmental vitiligo
by: Khaled Mohamed Tawfik, et al.
Published: (2020-01-01)

Efficacy and safety of 0.0015% tafluprost versus 0.005% latanoprost in primary open angle glaucoma, ocular hypertension: a Meta-analysis
by: Xi-Ting Yang, et al.
Published: (2020-03-01)

A novel fixed-combination timolol-netarsudil-latanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension
by: Tao Wang, et al.
Published: (2022-11-01)

Efficacy, Safety and Patient-Reported Outcomes with Preservative-Free (PF) Tafluprost or PF-Dorzolamide/Timolol Compared with Preserved Latanoprost: A Prospective Multicenter Study in Korean Glaucoma Patients with Ocular Surface Disease
by: Sang-Woo Park, et al.
Published: (2022-02-01)